Evidence map›Paper›PMID 38698591›Full record

ArticlePublic health nutrition2024

Did a workplace sugar-sweetened beverage sales ban reduce anxiety-related sugar-sweetened beverage consumption during the COVID-19 pandemic?

Laurie M Jacobs, Laura A Schmidt, Dean Schillinger, Jamey M Schmidt, Katie E Alegria, Bethany Parrett, Amanda Pickett, Elissa S Epel

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Public health nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laurie M JacobsPhilip R Lee Institute for Health Policy Studies, University of California at San Francisco, San Francisco, USA.
Laura A SchmidtPhilip R Lee Institute for Health Policy Studies, University of California at San Francisco, San Francisco, USA.
Dean SchillingerPhilip R Lee Institute for Health Policy Studies, University of California at San Francisco, San Francisco, USA.
Jamey M SchmidtSutter Health California Pacific Medical Center Research Institute, San Francisco, USA.
Katie E AlegriaDepartment of Psychiatry and Behavioral Sciences, University of California at San Francisco, San Francisco, USA.
Bethany ParrettSutter Health California Pacific Medical Center Research Institute, San Francisco, USA.
Amanda PickettSutter Health California Pacific Medical Center Research Institute, San Francisco, USA.
Elissa S EpelDepartment of Psychiatry and Behavioral Sciences, University of California at San Francisco, San Francisco, USA.

Funding

Translational Research Core - Health Engagement & Action Translational (HEAT)P30DK092924 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI Alyce Sophia Adams, HILARY Kessler SELIGMAN · 2011 to 2026
$9.2M
Stress, diet quality, and biological aging across the lifespanR24AG048024 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EPEL, ELISSA S., MENDES, WENDY BERRY · 2014 to 2025
$6.2M
Testing combinations of population interventions to encourage healthy eatingR01DK116852 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHILLINGER, DEAN · 2018 to 2022
$3.7M
Multi-Level Trial of a Workplace Sales Ban of Sugary Beverages and Brief Motivational Counseling Intervention on AdiposityR01DK132870 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Elissa S. Epel, Laura A Schmidt · 2022 to 2026
$3.5M
NCCDPHP CDC HHS U18 DP006526NIA NIH HHS R24 AG048024NIDDK NIH HHS R01 DK116852NIDDK NIH HHS R01 DK132870
6 · The paper itself

Abstract

objectiveWorkplace sugar-sweetened beverage (SSB) sales bans can reduce SSB consumption. Because stress and anxiety can promote sugar consumption, we examined whether anxiety among hospital employees during the COVID-19 pandemic was associated with changes in SSB consumption and explored whether this relationship varied by exposure to a workplace SSB sales ban.

designIn a prospective, controlled trial of workplace SSB sales bans, we examined self-reported anxiety (generalised anxiety disorder-7) and self-reported SSB consumption (fluid ounces/d) before (July 2019) and during (May 2020) the COVID-19 pandemic.

settingHospital sites in two conditions (four with SSB sales bans and three without sales bans) in Northern California.

participantsWe sampled 580 participants (hospital employees) from a larger trial of sales bans; all were regular consumers of SSB (minimum 3/week at main trial enrollment). This subsample was chosen based on having appropriately timed data for our study questions.

resultsAcross conditions, participants reduced SSB consumption over the study period. However, participants with higher pandemic-era anxiety scores experienced smaller reductions in SSB consumption after 9 months compared with those with lower anxiety scores (

conclusionsSSB sales bans likely reduce SSB consumption through multiple pathways; buffering stress-related consumption may be one mechanism.

Indexed as

AnxietyCOVID-19SARS-CoV-2Sugar-Sweetened BeveragesWorkplaceAdultCaliforniaCommerceFemaleHumansMaleMiddle AgedPandemicsPersonnel, HospitalProspective StudiesAnxietyCOVID-19 pandemicSugar-sweetened beveragesWorkplace interventions

Identifiers

PMID38698591
PMCPMC11374549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.